Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Xiang Wang, MD
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Study Director - Xudong Yao, MD
Shanghai Tenth People's Hospital,Shanghai Tong Ji University School of Medicine
Study Director - Yushan Liu, MD
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
- Shanghai General Hospital,shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
- Shanghai Ninth People'S Hospital,shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
- Shanghai Tenth People'S Hospital,shanghai Tong Ji University School of Medicine
Shanghai, Shanghai Municipality, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Jun 2021
- Primary completion
- 11 Jul 2024
- Completion
- 31 Dec 2024
- Last update posted
- 12 Jul 2024
- Registered enrollment
- 25
- Registry id
- NCT04706598
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.